Last quarter (Q ), GlobeImmune's total revenue was $942.75K, a decrease of -20.63% from the same quarter last year. In Q, GlobeImmune's net income was $-862.21K. See GlobeImmune’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 15	Dec 14	Dec 13	Dec 12	Dec 11
Total Revenue	$ 6.21M	$ 6.46M	$ 5.97M	$ 22.52M	$ 14.64M	$ 5.11M
Cost of Revenue	-	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ 5.27M	$ 6.46M	$ 5.97M	$ 22.52M	$ 14.64M	$ 5.11M
Operating Expense	$ 8.28M	$ 9.22M	$ 11.79M	$ 14.83M	$ 18.61M	$ 17.70M
Operating Income	$ -2.07M	$ -2.77M	$ -5.82M	$ 7.69M	$ -3.97M	$ -12.59M
Net Non Operating Interest Income Expense	-	-	$ -3.89M	$ 0.00	$ 0.00	$ 0.00
Other Income Expense	-	-	$ -6.55M	$ 1.90M	$ 1.95M	$ -1.13M
Pretax Income	$ -2.07M	$ -2.77M	$ -16.26M	$ 9.59M	$ -2.01M	$ -13.72M
Tax Provision	-	-	$ 0.00	$ 115.77K	$ 0.00	$ 0.00
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -2.07M	$ -2.77M	$ -23.43M	$ -3.41M	$ -14.12M	$ -25.04M
Basic EPS	$ -0.36	$ -0.48	$ -8.04	$ 2.60	$ -147.65	$ -261.88
Diluted EPS	$ -0.39	$ -0.48	$ -8.04	$ 2.60	$ -147.65	$ -261.88
Basic Average Shares	$ 23.01M	$ 5.75M	$ 2.91M	$ 2.95M	$ 95.62K	$ 95.62K
Diluted Average Shares	$ 24.20M	$ 5.75M	$ 2.91M	$ 2.95M	$ 95.62K	$ 95.62K
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 8.28M	$ 9.22M	$ 11.79M	$ 14.83M	$ 18.61M	$ 17.70M
Net Income From Continuing And Discontinued Operation	$ -2.07M	$ -2.77M	$ -16.26M	$ 9.48M	$ -2.01M	$ -13.72M
Normalized Income	$ -2.07M	$ -2.77M	$ -9.71M	$ 8.24M	$ -3.97M	$ -12.59M
Interest Expense	-	-	$ 3.89M	$ 0.00	$ 0.00	$ 0.00
EBIT	$ -2.07M	$ -2.77M	$ -12.37M	$ 7.69M	$ -2.01M	$ -13.72M
EBITDA	$ -1.94M	$ -2.58M	$ -12.08M	$ 8.46M	$ -1.09M	$ -12.77M

Currency in USD

GlobeImmune Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing